Taxotere – Permanent Hair Loss (Alopecia)

 

What Is Taxotere

Taxotere® (docetaxel) is a chemotherapy drug manufactured by Sanofi-Aventis. Taxotere® was first approved in 1996 and is used to treat breast cancer, prostrate cancer, stomach cancer, head and neck cancer, and certain lung cancers. It is administered intravenously and can be used alone or with other drugs. A common combination therapy for breast cancer patients is called TAC chemotherapy which includes Taxotere®, Adriamycin (doxorubicin) and cyclophosphamide.

What Is The Taxotere Litigation About?

Taxotere® has been linked to permanent hair loss, but Sanofi-Aventis did not adequately warn of this risk until after a report by the FDA in December of 2015. FDA Statement. Prior to this label change, Sanofi-Aventis said “hair generally grows back.” Lawsuits against Taxotere’s® manufacturer generally allege that the drug causes permanent hair loss, that the manufacturer failed to adequately warn of this risk, and that there is an alternative medication that is as effective without the risk of permanent hair loss. Texas Case; California Case; Illinois Case; Colorado Case; Ohio Case.

What Does It Cost To Find Out If I Have A Case?

Nothing. Call us toll free at (877) 704-7674 for a free case evaluation. You’ll speak to a lawyer with more than 20 years of experience, not a case screener. We will take the time to discuss your case and your legal options. If your case proceeds to the investigation and litigation phase, we cover those costs. We are paid for our time and repaid for case expenses only if you make a financial recovery in the form of a settlement or verdict.

When Can I Expect A Settlement?

The Taxotere® litigation is just starting. Only a small number of cases have been filed around the country. There have been no Taxotere® trials or reports of settlements. Don’t let the early stage of this litigation cause you to delay. You have a legal deadline (called the statute of limitations) to file your case and failure to meet that deadline will cause you to lose your right to pursue your claim. Depending on the circumstances of your case, this deadline to file suit could be fast approaching. Call us toll free at (877) 704-7674 so that we can protect your right to pursue your case.

What Does Medical Science Say About Taxotere® And Permanent Hair Loss?

To learn more about Taxotere® and permanent hair loss, see the medical literature below.

Permanent Scalp Alopecia, Annals of Oncology

Permanent Alopecia After Systemic Chemotherapy, American J. Dermatopathol.

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer, New England J. of Medicine

Docetaxel in Node Positive Adjuvant Breast Cancer (TAX316)